Updates

CSRxP Applauds Secretary Azar’s Focus on List Prices

Jun 26, 2018

CSRxP spokesman Will Holley released the following statement in response to… Read More

CSRxP Testimony for the Record: Senate Finance Committee Hearing on Rx Prices

Jun 25, 2018

The Campaign for Sustainable Rx Pricing today released testimony for the… Read More

CSRxP Applauds Senate Judiciary Committee for Vote on CREATES Act

Jun 14, 2018

“We applaud the members of the Senate Judiciary Committee for voting the… Read More

CSRxP Statement on Secretary Azar’s Testimony in Front of Senate HELP Committee

Jun 12, 2018

“When the manufacturer-set price of a drug starts out high… Read More

46 Signatories Applaud Grassley & Feinstein for CREATES Act Markup

Jun 7, 2018

46 organizations today applauded Chairman Chuck Grassley and Ranking Member… Read More

CSRxP Statement on HHS OIG Part D Spending Report

Jun 4, 2018

Today, the Office of the Inspector General at the Department of Health and… Read More

CSRxP Applauds FDA’s Focus on REMS Abuses

May 31, 2018

The Campaign for Sustainable Rx Pricing released the following statement… Read More

CSRxP Applauds FDA’s Transparency on Brand “Gaming” Tactics

May 17, 2018

The Campaign for Sustainable Rx Pricing released the following statement… Read More

CSRxP on President Trump’s Remarks on Drug Prices

May 11, 2018

The Campaign for Sustainable Rx Pricing released the following statement… Read More

CSRxP Launches TV & Digital Ad Campaign Urging Congress to Pass the CREATES Act

Mar 8, 2018

March 8, 2018 Contact: [email protected] ( 202) 286-4682 The Campaign for… Read More

CSRxP Statement on Nomination of Alex Azar to be Secretary of Health and Human Services

Nov 17, 2017

The Campaign for Sustainable Rx Pricing released the following statement… Read More

Vizient Joins CSRxP as 30th Member of the Coalition

Sep 21, 2017

“We are excited to join CSRxP and be a part of the coalition to achieve reasonable prescription drug prices,” says Jody Hatcher, president, sourcing and collaboration services at Vizient. “Our health care members are facing enormous financial and clinical pressures associated with pharmaceuticals. Read More